Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

Acta Derm Venereol. 2022 Dec 13:102:adv00835. doi: 10.2340/actadv.v102.4490.
No abstract available

MeSH terms

  • Autoantibodies
  • Desmoglein 1
  • Humans
  • Immunoglobulin G
  • Pemphigus* / diagnosis
  • Pemphigus* / drug therapy
  • Rituximab / adverse effects

Substances

  • Autoantibodies
  • Immunoglobulin G
  • Rituximab
  • Desmoglein 1